"Emerging isosteric replacement methods: a fundamental strategy in drug design"
A half day symposium with a great line-up of speakers!
August 23rd, 2016, Philadelphia, PA 8:30 AM to 12:15 PM Pennsylvania Convention Center, Room 114
Dr. Nicholas A. Meanwell | BMS (USA) | General Concepts and New Trends,
Dr. Nathan Brown | Cancer Research (UK) | In-Silico Design,
Dr. Antonia Stepan | Pfizer (USA) | Arene -> Bicyclo[1.1.1]pentane Switch and Case studies,
Prof. John F. Hartwig | Berkeley (USA) | Fluorine, Boryl, Silyl, Amino groups as bio-isosteres,
Prof. Craig Williams | University of Queensland (Australia) | Cubanes,
Prof. Erick M. Carreira | ETH Zürich (Switzerland) | Oxetanes, Spirocycles, SF5, fluoroalkyls groups,
Dr. Matthew Duncton | Rigel Therapeutics (USA) | Carboxylic Acids -> Tetrazolones,
Prof. Gary Molander | Upenn (USA) | Methods of late-stage introduction of bio-isosteric groups,
Chair: Dr. Thomas C. Fessard, SpiroChem, (Switzerland)